Azacitidine

ATC Code L01BC07

Azacitidine

Definition

A pyrimidine nucleoside analogue of cytidine with antineoplastic activity. Azacitidine is incorporated into DNA, where it reversibly inhibits DNA methyltransferase, thereby blocking DNA methylation. Hypomethylation of DNA by azacitidine may activate tumor suppressor genes silenced by hypermethylation, resulting in an antitumor effect. This agent is also incorporated into RNA, thereby disrupting normal RNA function and impairing tRNA cytosine-5-methyltransferase activity. (NCI04)

Also known as 4-Amino-1-beta-D-ribofuranosyl-1,3,5-triazin-2(1H)-one, 5 AZC, 5-AC, 5-Aza-cytidine, 5-Azacitidine, 5-Azacytidine, 5-AZC, AZACITIDINE, Azacytidine, Azacytidine, 5-, Ladakamycin, Mylosar, U-18496, Vidaza — per NCIT

Also identified as

Indications

Disease Relation Source
Chronic myelomonocytic leukemia may treat MEDRT · Public domain (U.S. Government work)
Myelodysplastic syndrome with single lineage dysplasia may treat MEDRT · Public domain (U.S. Government work)
Sideroblastic anemia may treat MEDRT · Public domain (U.S. Government work)

Organ Effects

Organ Side effect / interaction Source
Bone marrow may treat a disease of this organ DERIVED · CC BY 4.0

1 entry above is marked DERIVED: Atlas Médico inferred it by combining two sourced claims, and no source asserts this link directly. Treat it as a navigation aid, not as a clinical statement.